Dinitrophenyl (DNP)

Dinitrophenyl (DNP) is a highly immunogenic small molecule, or hapten, that is not naturally found in the human body. In the field of biotechnology and medicine, it is primarily utilized as a synthetic target in modular immunotherapy platforms, such as universal Chimeric Antigen Receptor (CAR) T-cell systems. In these systems, CAR-T cells are engineered to recognize the DNP moiety, while tumor specificity is provided by DNP-conjugated 'adapter' antibodies that bind to specific cancer antigens. This approach allows a single CAR-T product to be redirected against various tumor types by simply changing the adapter molecule. Additionally, DNP has been used to chemically modify tumor cells in clinical-stage cancer vaccines, such as DNP-Vax, to increase their immunogenicity and break immune tolerance. Beyond its role as an immunological tag, the specific derivative 2,4-dinitrophenol is a potent mitochondrial uncoupler that dissipates the proton gradient across the inner mitochondrial membrane, leading to increased metabolic rate and heat production. While historically used for weight loss, it is currently being investigated for potential roles in treating metabolic and neurodegenerative diseases.

Other names

2,4-DinitrophenylDNP groupDNP hapten2,4-Dinitrophenyl (DNP) group

Serves as a synthetic epitope for engineered anti-DNP Chimeric Antigen Receptor (CAR) T-cells in modular 'universal' cell therapy platforms; acts as a hapten to enhance the immunogenicity of weakly antigenic tumor proteins in cancer vaccines; or (as 2,4-dinitrophenol) uncouples mitochondrial oxidative phosphorylation to increase energy expenditure.